NooCamilon Picamilon 50 By LifeLink Overview & Drug Interactions

Check For Interactions With NooCamilon Picamilon 50

Supplement: NooCamilon Picamilon 50 by LifeLink

NooCamilon Picamilon 50 Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with NooCamilon Picamilon 50 by LifeLink

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
4 Capsule(s)
UPC/BARCODE 639793301416

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Picamilon
50 mg
Picamilon --

Other Ingredients:
Microcrystalline Cellulose
Gelatin


Label Statments:


Suggested/Recommended/Usage/Directions
- Suggested Use: 1-4 capsules daily in divided doses or as directed by a health care professional.
FDA Statement of Identity
- DIETARY SUPPLEMENT
General Statements
- Picamilon is a nutraceutical developed in Russia for improving mood, learning, memory, vision, and other neurological functions. See our website for details: www.lifelinknet.com/siteResources/Products/NooCamilon.asp

Brand Information

See all products by this brand

Manufacturer
Name LifeLink
City Grover Beach
State CA
ZipCode 93433
Web Address http://www.lifelinknet.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.